Histogenics Corporation Announces Appointment Of Kathleen Large, R.N., M.S., To Vice President Of Clinical Operations
7/2/2014 9:45:07 AM
Histogenics Corporation, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced the appointment of Kathleen Large, R.N., M.S., to Vice President of Clinical Operations. Ms. Large brings over 20 years of leadership and experience in the pharmaceutical and medical industries, including expertise in the strategy, design and execution of large global clinical programs. Ms. Large will be responsible for management of Histogenics’ clinical programs, including the ongoing Phase 3 trial of NeoCart®, studying the treatment of certain knee cartilage injuries.
Help employers find you! Check out all the jobs and post your resume.
comments powered by